From Casetext: Smarter Legal Research

Engle v. the Purdue Pharma Company

United States District Court, S.D. Texas, Houston Division
Sep 2, 2005
Civil Action No. H-04-2407 (S.D. Tex. Sep. 2, 2005)

Opinion

Civil Action No. H-04-2407.

September 2, 2005


MEMORANDUM AND ORDER


This case is one of many currently pending in federal courts across the country, seeking damages for personal injuries allegedly resulting from use of the prescription drug OxyContin. On June 21, 2005, a Petition for Transfer, Coordination and Consolidation ("the Petition") was filed, pursuant to 28 U.S.C. § 1407, with the Joint Panel on Multi-District Litigation ("JPML"). The Petition seeks multi-district coordination of OxyContin cases and consolidation of those cases in the Southern District of Illinois. Plaintiffs have filed a motion to stay discovery pending the resolution of the Petition.

The Court has considered the parties' filings and oral arguments. This case involves plaintiff-specific factual issues that can most efficiently be resolved if discovery on those issues proceeds now. Therefore, Plaintiffs' motion to stay discovery is DENIED.

IT IS SO ORDERED.


Summaries of

Engle v. the Purdue Pharma Company

United States District Court, S.D. Texas, Houston Division
Sep 2, 2005
Civil Action No. H-04-2407 (S.D. Tex. Sep. 2, 2005)
Case details for

Engle v. the Purdue Pharma Company

Case Details

Full title:MICHAEL R ENGLE, et al., Plaintiffs, v. THE PURDUE PHARMA COMPANY, et al.…

Court:United States District Court, S.D. Texas, Houston Division

Date published: Sep 2, 2005

Citations

Civil Action No. H-04-2407 (S.D. Tex. Sep. 2, 2005)